Newswire
ภาษาไทย
English-
CISION PR Newswire - Global Times: Up Close: President Xi joins nationa...
BEIJING, March 9, 2025 /PRNewswire/ -- Chinese President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, vis... -
CISION PR Newswire - Appian Unveils Latest Platform Release for Faster,...
SYDNEY, March 10, 2025 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced the latest version of the Appian Platform, which delivers improved scalability, speed, and performance for enterpris... -
CISION PR Newswire - AIM Vaccine's Iteratively Upgraded Diploid Rabies ...
HONG KONG, March 10, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 9, 2025, the company's research and development of a diplo... -
CISION PR Newswire - U.S. FDA approves Celltrion's OMLYCLO® (omalizumab...
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating com... -
CISION PR Newswire - China Telecom and Partners Innovate Together! 5G U...
HONG KONG, March 10, 2025 /PRNewswire/ -- On March 5, during the 2025 Mobile World Congress (MWC25), the 5G UAV medical delivery network solution jointly developed by China Telecom, Hangzhou Antwork N... -
CISION PR Newswire - Webull Singapore launches trading competition for ...
SINGAPORE, March 10, 2025 /PRNewswire/ -- Webull Securities (Singapore) Pte Ltd ("Webull Singapore"), a subsidiary of Webull Corporation, a leading digital investment platform, has officially l... -
CISION PR Newswire - RiboX Therapeutics Announces First Patient Dosed i...
PRINCETON, N.J., March 10, 2025 /PRNewswire/ -- RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutic... -
CISION PR Newswire - Thai Scientists from Chula to Investigate Global W...
BANGKOK, March 10, 2025 /PRNewswire/ -- Prof. Dr. Suchana Chavanich from the Department of Marine Science, Faculty of Science, and Deputy Director of the Aquatic Resources Research Institute, Chulalon... -
CISION PR Newswire - HASHKEY GLOBAL PARTNERS WITH VERIFYVASP TO EXPAND ...
Strategic partnership strengthens regulatory compliance across HashKey Global's international exchange network. SINGAPORE, March 10, 2025 /PRNewswire/ -- HashKey Global, a leading licensed exchange, a... -
CISION PR Newswire - Doer Biologics Completes Enrollment of the Phase 2...
HANGZHOU, China, March 10, 2025 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic di...
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ELITE Beauty.